STOCK TITAN

Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Procaps Group (NASDAQ: PROC) to host conference call on November 16, 2023, at 10:30 a.m. Eastern Time to discuss third quarter and nine months 2023 results. The leading integrated LatAm healthcare and pharmaceutical services company will report its financial results for the period ended September 30, 2023, after market closes on November 14, 2023.
Positive
  • None.
Negative
  • None.

Company to Host Conference Call on Thursday November 16, 2023 at 10:30 a.m. Eastern Time

MIAMI & BARRANQUILLA, Colombia--(BUSINESS WIRE)-- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical services company, announced it will report its results for the third quarter and nine months ended September 30, 2023, after market closes on Tuesday, November 14, 2023.

The Company will host a conference call and webcast on Thursday, November 16, 2023, at 10:30 a.m. Eastern time, to discuss the third quarter and nine months 2023 results.

To access the call, please use the following information:

Date:

Thursday, November 16, 2023

Time:

10:30 a.m. ET

Webcast:

Click here to access

Toll Free dial-in number:

1-844-204-8586

Toll/International dial-in number:

1-412-317-6346

HD Web Phone:

Click here

Conference ID:

Procaps Group

The conference call will be broadcast live and available for replay here and via Procaps’ investor relations website.

A telephone replay will be available approximately two hours after the call and will run through November 23, by dialing 1-877-344-7529 from the U.S., or 1-412-317-0088 from international locations and entering replay pin number: 4127390.

About Procaps Group

Procaps Group, S.A. (“Procaps”) (NASDAQ: PROC) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5,500 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products and prescription pharmaceutical drugs (Rx), nutritional supplements and high-potency clinical solutions.

For more information, visit Procaps’ investor relations website investor.procapsgroup.com.

Investor Contact:

Melissa Angelini

ir@procapsgroup.com

investor.procapsgroup.com

Source: Procaps Group, S.A.

FAQ

When will Procaps Group host the conference call to discuss the third quarter and nine months 2023 results?

Procaps Group will host the conference call on November 16, 2023, at 10:30 a.m. Eastern Time.

What is the ticker symbol of Procaps Group?

The ticker symbol of Procaps Group is NASDAQ: PROC.

How can I access the webcast of the conference call?

You can access the webcast by clicking on the provided link.

How can I access the toll-free dial-in number for the conference call?

The toll-free dial-in number for the conference call is 1-844-204-8586.

When will the telephone replay of the conference call be available?

The telephone replay will be available approximately two hours after the call and will run through November 23.

Procaps Group, S.A. Ordinary Shares

NASDAQ:PROC

PROC Rankings

PROC Latest News

PROC Stock Data

205.34M
112.82M
83.03%
2.94%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Luxembourg